Susceptibility-weighted angiography for the detection of high-flow intracranial vascular lesions: preliminary study

Hodel, Jérôme; Blanc, Raphaël; Rodallec, Mathieu; Guillonnet, Antoine; Gerber, Sophie; Pistocchi, Silvia; Sitta, Rémi; Rabrait, Cécile; Zuber, Mathieu; Pruvo, Jean-Pierre; Zins, Marc; Leclerc, Xavier
April 2013
European Radiology;Apr2013, Vol. 23 Issue 4, p1122
Academic Journal
Objectives: Susceptibility-weighted magnetic resonance imaging (MRI) sequences may demonstrate various signal intensities of draining veins in cases of high-flow vascular malformation (HFVM), including arteriovenous malformation (AVM) and dural arteriovenous fistula (dAVF). Our objective was to evaluate susceptibility-weighted angiography (SWAN) for the detection of HFVM. Methods: Fifty-eight consecutive patients with a suspected intracranial vascular malformation were explored with SWAN and post-contrast MRI sequences at 3 T. The diagnosis of slow-flow vascular malformation (SFVM), including developmental venous anomaly (DVA) or brain capillary telangiectasia (BCT), was based on MRI. Patients with suspected HFVM underwent digital subtraction angiography (DSA). SWAN images were analysed by three blinded readers according to a three-point scale of the venous signal. Results: Thirty-one patients presented 35 SFVM (26 DVA and 9 BCT) that systematically appeared hypointense on SWAN images. In patients with atypical MRI findings, DSA revealed one patient with an atypical DVA and 26 patients with HFVM (22 AVM and 4 dAVF). SWAN revealed at least one venous hyperintensity in all patients with HFVM. Agreement between readers was excellent. Conclusions: SWAN appears reliable for characterising blood flow dynamics in brain veins. In clinical practice, SWAN can routinely rule out HFVM in patients with atypical brain veins. Key Points: • Susceptibility- weighted angiography (SWAN) offers new perspectives for detecting intracranial vascular malformations. • SWAN sequence provides non- invasive characterisation of blood flow dynamics. • SWAN can differentiate between high and slow flowing venous blood. • SWAN can routinely rule out high- flow vascular malformations.


Related Articles

  • Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: a comparative study versus standard digital angiography. Chris Pavlovic; Hideki Futamatsu; Dominick Angiolillo; Luis Guzman; Norbert Wilke; Daniel Siragusa; Peter Wludyka; Robert Percy; Martin Northrup; Theodore Bass; Marco Costa // International Journal of Cardiovascular Imaging;Apr2007, Vol. 23 Issue 2, p225 

    AbstractObjective??The purpose of this study is to evaluate the accuracy of semiautomated analysis of contrast enhanced magnetic resonance angiography (MRA) in patients who have undergone standard angiographic evaluation for peripheral vascular disease (PVD).Background??Magnetic resonance...

  • Time-resolved MR angiography of the calf arteries using a phased array cardiac coil: comparison of visibility with standard three-step bolus chase MR angiography. Eshed, Iris; Rimon, Uri; Novikov, Ilia; Goitein, Orly; Konen, Eli // Acta Radiologica;Nov2011, Vol. 52 Issue 9, p973 

    Background: Standard bolus chase MR angiography (MRA) is increasingly replacing digital subtraction angiography (DSA) in the diagnostic evaluation of peripheral vascular disease. However, a major limitation of bolus chase MRA is the relatively poor visibility of the calf arteries. Purpose: To...

  • GADOLINIUM-ENHANCED MRA AND MRI IN PERIPHERAL VASCULAR MALFORMATIONS. Gervas, C.; Limusin, B.; Recondo, J.A.; Merino, S. // Acta Radiologica;Apr2000 Supplement 422, Vol. 41, p59 

    Determines the value of gadolinium-enhanced magnetic resonance angiography and imaging in the diagnosis of peripheral vascular malformations. Diagnostic sensitivity and specificity; Comparison with catheter angiography.

  • Bolus-chasing contrast-enhanced 3D MRA of the lower extremity. Comparison with intraarterial DSA. Steffens, J. C.; Schäfer, F. K. W.; Oberscheid, B.; Link, J.; Jahnke, T.; Heller, M.; Brossmann, J.; Schäfer, F K W // Acta Radiologica;Mar2003, Vol. 44 Issue 2, p185 

    Purpose: To evaluate step-table 3D contrast-enhanced (CE) MRA with bolus chasing for the detection and grading of stenoses in patients with peripheral vascular disease (PVD) of the lower extremities.Material and Methods: Fifty patients were studied by step-table...

  • Peripheral contrast-enhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience. Nael, Kambiz; Krishnam, Mayil; Nael, Ali; Ton, Anthony; Ruehm, Stefan G.; Finn, J. Paul // European Radiology;Dec2008, Vol. 18 Issue 12, p2893 

    To investigate a high spatial resolution peripheral contrast-enhanced MR angiography (CE-MRA) protocol, applying a dedicated multi-channel array coil and accelerated parallel acquisition at 3.0T in evaluation of patients with peripheral vascular disease. Twenty patients with peripheral vascular...

  • What is the best test for peripheral vascular disease? Hull, Sharon K.; Kishman Jr., Charles R. // Journal of Family Practice;Jun2008, Vol. 57 Issue 6, p403 

    The article reports on the study conducted to assess the best possible treatment of peripheral vascular disease (PVD) of patients in the U.S. Researchers found that PVD is a progressive atheroscletoric narrowing of arteries in the extremities and it prevailed as the person's age increases....

  • Carbon dioxide angiography for peripheral vascular intervention. Koch, G. G. V.; Robbs, J. V. // South African Radiographer;May2016, Vol. 54 Issue 1, p9 

    Carbon dioxide angiography (CDA) is a relatively modern technique performed during interventional vascular procedures. Compared to traditional angiography using iodinated contrast media (ICM), CDA poses very little risk to a patient. Carbon dioxide (CO2), as an imaging agent, is particularly...

  • Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018. Adis International Limited // Drugs in R&D;2004, Vol. 5 Issue 6, p339 

    Gadofosveset [MS 325, MS 32520, Vasovist, ZK 236018], a gadolinium-based chelate, is an injectable angiography imaging agent for use in magnetic resonance imaging (MRI) scans. The agent is being developed by EPIX Medical (formerly Metasyn) for diagnostic imaging of blood vessels of the...

  • Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature. Goyen, M.; Debatin, J. F. // European Radiology;Nov2003 Supplement 3, Vol. 13, pN19 

    Although limited in number, reports describing the use of Gd-BOPTA for 3D CE-MRA reveal that this agent is safe, well tolerated and effective for CE-MRA at doses up to 0.3 mmol/kg bodyweight. The use of Gd-BOPTA leads to additional diagnostically relevant information comparable to that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics